fashion -WSS

fashion

author：knowledge 2025-09-07 13:57:51 - browse：9

Drew Weissman (left) and Katalin Karikó (right) — Drew Weissman (left) and Katalin Karikó, whose longtime partnership was recognized with a Nobel Prize on Monday. Peggy Peterson/Penn Medicine

The most noteworthy aspect of awarding the Nobel Prize in medicine or physiology to two pioneers of mRNA research was not who won Monday — Katalin Karikó and Drew Weissman were widely expected to get the accolade for discoveries that made it possible to deliver the finicky molecule to cells and enabled the record-breaking development of vaccines that tamed the Covid-19 pandemic. It was the way the two scientists worked together.

The Nobel committee framed Karikó and Weissman’s work as a prime example of complementary expertise, with Karikó focused on RNA-based therapies and Weissman bringing a deep knowledge about immune responses to vaccines. In a rare moment for science’s top honor, which elevates the individual contributions of one, two, or at most, three researchers to a particularly impactful breakthrough, it is a celebration of a true scientific partnership — a durable and fruitful collaboration spanning more than two decades of working shoulder-to-shoulder at the lab bench that turned a scientific backwater into a blockbuster technology.

“We couldn’t get funding, we couldn’t get publications, we couldn’t get people to notice mRNA as something interesting,” Weissman told reporters at a press conference Monday at the University of Pennsylvania. “But Kati lit the match and we spent the rest of the next 20 plus years working together figuring out how to get it to work. We would sit together in 1997 and afterwards and talk about all the things we thought RNA could do. And that’s why we never gave up,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： How to use technology to prevent future drug shortages

explore

focus

WSS

How I helped Pfizer think through the ethics of Viagra

The best solution to the drug shortages problem

Personalized medicine goes far beyond genetics

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Personalized medicine goes far beyond genetics

focus

fashion

knowledge

The cancer drug shortage isn’t new — and neither are the solutions

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Affirmative action in medical school literally saved lives

How I helped Pfizer think through the ethics of Viagra

Apple is now the first public company to be valued at $3 trillion

Wegovy’s successful heart trial raises vital question about weight loss

Duchenne breakthrough therapy leaves behind pioneering families

The a glaring gap in research on serious mental illness and primary care

Medicare proposal to cover medical devices draws a mixed reaction

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

entertainment

CDC recommends RSV monoclonal antibody for infants

Emergent cuts jobs, executive role in business shake

CDC recommends RSV monoclonal antibody for infants

Chris Christie meets with Zelenskyy during Ukraine trip

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Biotech startup Celsius cuts 75% of staff ahead of first trial start

hotspot

explore

focus

hotspot